Bayer raises offer to buy Monsanto

The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014. German pharmaceutical and crops manufacturer Bayer AG said on Monday that its negotiations with Monsanto Co had advanced, and that it was now willing to offer more than $65 billion to acquire the world's largest seeds company. REUTERS/Ina Fassbender/File Photo

 

AFP

The German pharmaceutical and chemicals group Bayer said it would sweeten its offer for US rival Monsanto.
In a statement, Bayer said it would raise its offer for the US seed giant to $127.50 per share from $125. That would bring the deal’s total value to almost $66 billion including debt.
Monsanto confirmed Bayer’s improved bid for a friendly takeover and said it was evaluating the proposal, “as well as proposals from other parties and other strategic alternatives”.
It said there was no guarantee a deal would be struck.
Monsanto rejected Bayer’s previous offer in mid-July, saying it was “financially inadequate”, but left the door open to further discussions.
With its new offer, Bayer also said it has no intention of carrying out a hostile takeover.
The German daily Handelsblatt reported in mid-August that Bayer was considering a hostile bid if faced with ongoing opposition from Monsanto.
A deal would create a global leader in genetically modified seeds and pesticides.
Monsanto pursued its own takeover of Swiss Syngenta for more than a year as well as BASF SE’s agrochemicals unit, Bloomberg reported.
Germany’s BASF could still play the role of white knight helping Monsanto fend off Bayer’s bid, Bloomberg said in mid-July.
Bayer was down 0.20 percent in early trade on the Frankfurt stock exchange on Tuesday.

Leave a Reply

Send this to a friend